Skip to content

EBITDA at other companies

LENSAR, Inc. logo
LENSAR, Inc.LNSR
$3.37M+172%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
-$92.06M-46.3%
Precision Optics Corporation logo
Precision Optics CorporationPOCI
$11.14K+101%
Bausch + Lomb logo
Bausch + LombBLCO
$134M+483%
Johnson & Johnson logo
Johnson & JohnsonJNJ
Schering-Plough logo
Schering-PloughSGP

Other financials

Income statement

See full
Revenue$30.9M-18.5%
Gross profit$23.5M-17.1%
Operating income-$17.8M-67.0%
Net income-$15.9M-93.9%
EPS (diluted)-$0.38-90.0%

Balance sheet

See full
Cash & equivalents$17.6M-37.2%
Total debt$10.8M-10.1%
Total equity$267.3M-4.3%
Total assets$304.0M-2.9%

Cash flow

See full
Operating cash flow-$10.9M-23.3%
CapEx$759.0K+32.0%
Free cash flow-$11.7M-23.8%

Valuation

See full
Market cap$232.23M-56.8%
Enterprise value$225.49M-55.7%
P/S1.8×-1.8×

Profitability

See full
Gross margin77%+5.1pp
Operating margin-43.4%+128pp
Net margin-36.6%-867pp
FCF margin-16.9%+4.9pp

Returns & leverage

See full
Return on equity-17.1%+12.6pp
Debt / equity0.0×
Current ratio10.2×-2.5×

Where this comes from

Calculated from RxSight, Inc.’s reported figures.

$17.8Mebit+
$834.0KDepreciation Depletion & Amortization
=-$17M

The official record: RxSight, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about RxSight, Inc.'s ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RxSight, Inc.'s EBITDA?
RxSight, Inc. (RXST) reported EBITDA of -$17M in Q1 2026.
How has RxSight, Inc.'s EBITDA changed year-over-year?
RxSight, Inc.'s EBITDA decreased by 71.7% year-over-year, from -$9.9M to -$17M.
What is the long-term trend for RxSight, Inc.'s EBITDA?
Over 4 years (2021 to 2025), RxSight, Inc.'s EBITDA has grown at a -2.1% compound annual growth rate (CAGR), from -$48.81M to -$44.93M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.